ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 36 filers reported holding ELEVATION ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,547 | -26.3% | 230,136 | +69.0% | 0.00% | – |
| Q2 2023 | $206,970 | -16.5% | 136,165 | +4.4% | 0.00% | – |
| Q1 2023 | $247,722 | +291337.6% | 130,380 | +44.3% | 0.00% | – |
| Q4 2022 | $85 | -99.9% | 90,343 | -0.3% | 0.00% | – |
| Q3 2022 | $102,000 | +183.3% | 90,627 | +245.0% | 0.00% | – |
| Q2 2022 | $36,000 | -45.5% | 26,266 | 0.0% | 0.00% | – |
| Q1 2022 | $66,000 | -47.6% | 26,266 | +25.0% | 0.00% | – |
| Q4 2021 | $126,000 | +34.0% | 21,021 | +72.9% | 0.00% | – |
| Q3 2021 | $94,000 | – | 12,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,370,142 | $3,602,616 | 3.79% |
| Aisling Capital Management LP | 2,834,910 | $4,309,063 | 2.11% |
| venBio Partners LLC | 2,914,255 | $4,429,668 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $6,080,000 | 0.90% |
| Velan Capital Investment Management LP | 497,299 | $755,894 | 0.70% |
| Ikarian Capital, LLC | 1,149,490 | $1,747,225 | 0.28% |
| Samsara BioCapital, LLC | 830,565 | $1,262,459 | 0.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $1,368,000 | 0.21% |
| DAFNA Capital Management LLC | 450,000 | $684,000 | 0.19% |
| BVF INC/IL | 2,312,200 | $3,514,544 | 0.10% |